Apport de l’hexylaminolévulinate (Hexvix®) pour la prise en...

Progrès en Urologie 2013 / 11 Vol. 23; Iss. 13

Apport de l’hexylaminolévulinate (Hexvix®) pour la prise en charge des tumeurs de vessie non infiltrant le muscle (TVNIM) : résultats de l’étude observationnelle HOPE (Hexvix® Observational Patients Evaluation)

Jacqmin, D., Molinier, L., Irani, J., Jichlinski, P., De La Taille, A., Rabbani, M., Malavaud, B.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
23
Language:
french
Journal:
Progrès en Urologie
DOI:
10.1016/j.purol.2013.08.242
Date:
November, 2013
File:
PDF, 61 KB
french, 2013
Conversion to is in progress
Conversion to is failed